Biotech targets: Cramer's quality candidates

With some traditional drug companies starved for growth, Cramer thinks smaller biotechs may be in play. Which are worthy of investment?
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.